Follow us:
NEWS
Human naive iPSc – a powerful tool for your research. High viability, ease of maintenance and differentiation.
January 1st, 2017, the newest article based on Celther research on EGFRvIII expression among various cancer types.
Celther Polska has been awarded “WPROST Innovator” 2016 title in the Pharmacy category.
OUR OFFER
Primary cells isolated directly from tissue provide conditions that closely simulate a living model.
Start your iPS cell research with custom-made, high quality iPS cell lines.
Use adult human body cells provided by Celther to test safety of your drug candidates.
Use iNSc to drug discovery and weed out ineffective and potentially neurotoxic compounds.
Human iPS cells with 18 chromosome trisomy - High viability - Easy to culture
Take advantage of a complete "Drug discovery and development" service provided by Celther.
Genetic Engineering - Molecular and Cell Biology - Cell cultures and iPS cell cultures.
Synthesis, formulation, physicochemical and biocompability analysis of polymers.
VIDEOS
In vitro toxicity testing services
Celther provides highly specialized in vitro examination of potential drug candidate compounds, using a plethora of methods, including real time cell observation.
Celther Induced Cardiomyocytes
Celther presents spontaneously beating human iPSderived cardiomyocytes, an excellent tool for cardiotoxicity testing and discovery of novel cardiac drug targets.
COPYRIGHT © 2017 CELTHER POLSKA